PATENT CLAIM ANALYSIS

Application Number: 15761012
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "190100"]

Abstract:
The present invention provides antigens, for use in the treatment or prevention of  C. burnetii  infection. Also provided are nucleic acids encoding such antigens, and antibodies raised against such antigens.

Claim (Index 43):
An in vitro method for isolating antibodies that bind to  C. burnetii  protein antigen, said method comprising:\n a) immobilising on a surface (for example on a matrix within a column) one or more  C. burnetii  protein antigen(s) according to  claim 1 ; b) contacting the immobilised protein(s) with a solution containing antibodies that bind to the  C. burnetii  protein antigen(s); c) allowing said antibodies to bind to said  C. burnetii  protein antigen(s), thereby forming a bound complex of antibody and protein antigen(s); d) washing away any unbound antibody or protein; and e) eluting the bound antibodies from the surface, thereby providing affinity-purified antibodies.

Metadata:
- Claim Count in Document: 12.0
- Percentile: 90.0
- Lexical Diversity: 1.17241
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12557741', '11837264', '12614896', '14396881', '12988595']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6857663506006244
- 35 USC 102 Novelty (BERT): 0.5100208540882577
- Combined Prediction Score: 0.6681918009493878
- Mean Citation Score: 259.467096
- Max Citation Score: 263.20352
- Similarity Product: 189.0446356617546

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test